Sanjiv J. Shah, MD, and Robert F. Kushner, MD, join a thought-leader panel to share their insights on the connection between diabetes and heart disease, as well as using semaglutide medication for prevention. They discuss the outcomes of their recent clinical trial studies published in the New England Journal of Medicine, SELECT and STEP-HFpEF.
These studies aimed to measure the effects of semaglutide in patients with obesity and pre-existing cardiovascular disease, and Dr. Kushner and Dr. Shah explain how the studies’ results complement each other and inform patient care.
Dr. Shah is director of Research at Northwestern Medicine Bluhm Cardiovascular Institute and Dr. Kushner is professor of Endocrinology at Northwestern Medicine.